In conclusion, we found that the level of ferroptosis is correlated with the antitumor efficacy of anti-PD-1 therapy, and RSL-induced ferroptosis promoted the efficiency of anti-PD-1 treatment in a syngeneic tumor model challenged by MC-38 cells. The gene discussed is PDCD1; the disease is neoplasm.